Neil G. Barry IV (@nbarry4) profile picture

Believer, Husband, Father, Interventional Cardiologist, Golf, Ski and Lake fanatic. I am too verbose for twitter. #TAVR #CHIP #SHOCK

Knoxville, TN
Joined October 2010
Photo by Neil G. Barry IV (@nbarry4)Photo by Neil G. Barry IV (@nbarry4)Photo by Neil G. Barry IV (@nbarry4)
The Triple Wire Dual Angioseal Technique for Large Bore Femoral Access Closure, by Hilal Khan & Mohaned Egred onlinelibrary.wiley.com/doi/… @ccijournal
2
6
37
4,486
Neil G. Barry IV retweeted
🚨 Statins do not just lower cholesterol. They lower your risk of dying from anything, not just a heart attack. The internet says statins are overprescribed poison. But the data says otherwise. And no, this is not industry spin. This is 30 years of independent replication. I am a cardiologist. I have thousands of patients on statins. I have watched this data hold up trial after trial, decade after decade. Here is what the science actually says. 🫀 1994. The 4S trial. Simvastatin cut all-cause mortality by 30% in coronary patients. RR 0.70, 95% CI 0.58 to 0.85. 8.5% died on the drug versus 11.5% on placebo. One life saved for every 33 people treated. 💓 Then the confirmations stacked up. ✅ HPS (simvastatin): all-cause mortality reduced 13% in 20,536 high-risk patients. RR 0.87. ✅ WOSCOPS (pravastatin): 32% reduction in coronary mortality, primary prevention, 6595 men with no prior heart disease. ✅ LIPID (pravastatin): 24% reduction in coronary mortality, 9014 patients. 🔬 Then the pooled data. The CTT Collaboration analyzed individual patient data from over 170,000 people. Vascular mortality fell roughly 12% per 1 mmol/L LDL reduction. Primary and secondary prevention both benefit. USPSTF 2022: RR 0.92 across 18 trials, 85,186 participants. I squared of 0%. Zero heterogeneity. NNT around 286 over 1 to 6 years. Even Byrne et al's more skeptical 2022 analysis found a 9% relative reduction in all-cause mortality. His real point was that doctors need to communicate absolute risk honestly. I agree with that completely. Nowak's 2022 observational meta-analysis of 54 studies found HR 0.72 for all-cause mortality. Same signal, different method. 🩺 What about older patients? A VA study of veterans 75 and older with no prior heart disease found HR 0.75 for all-cause mortality over 6.8 years. Age alone is not a reason to stop a statin. That study is observational, so I hold it more loosely than a randomized trial, but the signal is consistent with everything else. The question is no longer whether statins work. The question is how to personalize them and communicate the real numbers. Absolute benefit is larger in secondary prevention, often 1% to 3% over 5 years. In primary prevention it is smaller, around 0.35% to 0.8%. Smaller is not zero. It is still real. 🔬 Mechanism. Statins lower ApoB particle burden. Fewer atherogenic particles in your arteries means less plaque, less rupture, fewer deaths. This is not mysterious. It is biology doing exactly what we would predict. ⚠️ What about the non-statin drugs? 🔸 PCSK9 inhibitors: alirocumab showed a 15% reduction in all-cause death, but it missed formal hierarchical significance. Evolocumab showed no mortality benefit at all. 🔸 Ezetimibe: 26 trials, 23,499 patients, no effect on all-cause mortality. 🔸 Fibrates: no mortality benefit in the statin era. Niacin: no benefit, trending toward harm in the best trials. ❌ None of these classes have matched what statins have shown. ❤️ Bottom line: Statins are not just a number on a lab report. They are one of the most reproducible mortality interventions in medicine. This is not one trial. This is decades of randomized data, pooled data, and observational data all pointing the same direction. Take your statin if prescribed. Ask your doctor for your actual absolute risk, not just the relative number. Do not stop because you turned 75. A patient who stays on their statin for 5 years can cut their absolute risk of death by 1% to 3% if they have known heart disease. That is the difference between a funeral and a birthday. Why are so many people convinced a drug with this much evidence is dangerous? #Cardiology #HeartDisease #HeartHealth #CardiovascularHealth #Statins #ApoB #LDL #C
13
24
3
128
10,554
Neil G. Barry IV retweeted
Among patients with syncope that remained unexplained after evaluation in the ED, immediate initiation of 14-day ECG monitoring did not result in significantly fewer patient-reported syncope episodes at 1 year than standard care. Full ASPIRED trial results and Research Summary: nej.md/4wH7SJh #ESCCongress
2
20
2
112
20,409
🫀 Can coronary atherosclerosis actually regress? Our new randomized FLOWPROMOTE trial analysis, published TODAY in JAMA Cardiology, shows remarkable coronary plaque regression with intensive LDL-C lowering! Atherosclerosis is not necessarily a one-way process. 📄 JAMA Cardiology: doi.org/10.1001/jamacardio.2… #Atherosclerosis #LDL #Cardiology #CCTA
79
382
59
1,392
264,476
Neil G. Barry IV retweeted
Had a few cases where I needed to remove the GEC without pulling out the balloon or stent catheter. Always thought a peel-away option would be great. Today, I improvised one. Should manufacturers provide a dedicated slitter tool, or is this too niche a problem? #CHIP #PCI
4
6
26
14,387
Neil G. Barry IV retweeted
Web flow disruptor +/- stent. Here’s the link. Lesion in is not surgically accessible. jacc.org/doi/10.1016/j.jcin.…
Here an interesting case. How would you approach this wide base LM bifurcation aneurysm? Pt with severe calcific CAD and angina
2
8
39
8,838
Neil G. Barry IV retweeted
Melatonin is often seen as a harmless natural sleep aid. I have used it myself when residency wrecked my body clock. But a large preliminary study presented at the AHA linked use for ≥1 year in people with insomnia to a 90% higher heart-failure risk over 5 years.
118
173
29
862
91,867
A nice case of bailout endovascular betrieval of a severely kinked guiding catheter during primary PCI for inferior STEMI using macro snare and controlled counter-traction, courtesy of Catheterization & Cardiovascular Interventions onlinelibrary.wiley.com/doi/… @ccijournal
1
11
27
2,547
Neil G. Barry IV retweeted
When faced with a conduit shortage, this video illustrates how to harvest the lesser saphenous vein with a single operator and patient in a supine position
Surgeons at @CleClinicHVTI found using an internal thoracic artery retractor to vertically suspend the patient's leg provides convenient access to the lesser saphenous vein, allowing single-operator harvesting. Read in #JTCVS Techniques: hubs.la/Q04x2BjS0 @FaisalBakaeen
1
5
1
55
21,233
Neil G. Barry IV retweeted
When a patient with severe aortic regurgitation was found to have irreparable valve damage during surgery, S. Christopher Malaisrie, MD (@ChrisMalaisrie), and the Northwestern Medicine team adapted the surgical plan and performed a minimally invasive aortic valve replacement through a right anterior minithoracotomy. Watch the full video: breakthroughsforphysicians.n…
1
4
16
3,415
Neil G. Barry IV retweeted
BIG NEWS: CMS final TAVR coverage decision, biggest change to TAVR coverage since 2012. Here’s my summary from the long 105-page statement: - Symptomatic severe aortic stenosis is now covered as standard care. No mandatory registry enrollment. - Asymptomatic severe aortic stenosis is newly covered, but only for patients enrolled in Medicare-approved studies. - The heart team stays. Every patient still needs input from both cardiac surgery and interventional cardiology (can be done through chart review), plus an in-person visit with one TAVR operator before the day of the procedure. - The two-operator requirement is gone. Now one qualified operator can do the case alone. - Two operators are still covered if the heart team decides they’re needed and that can be in any combination: surgeon + interventional cardiologist, two interventional cardiologists, or two surgeons. - Volume requirements now apply to the operator, not the hospital: at least 20 transcatheter valve cases a year (15 of them TAVR). - Hospitals still need on-site cardiac surgery program. @6ayyeboon @AlkashkariWail @mirvatalasnag @BinAbdulHak_A @amrmohsen213 @MarwanSaadMD @aelsab @MusaSharkawi @MohammedQintar @mhammadah @JDDCFratti @acamajmd @Almanfi_Cardio @scottiejj12
7
30
3
83
18,278
Neil G. Barry IV retweeted
This is sad, brilliant, and accurate! Patients and physicians are both stuck in a purgatory-like system! Another great video by @crowdhealth
This quoted post is unavailable.
3
18
6
154
26,568
Neil G. Barry IV retweeted
This is a big bust, folks The first large scale (N>8000 participants) for lowering Lp(a) did not meet its primary endpoint for reducing adverse cardiovascular outcomes (vs placebo) novartis.com/news/media-rele…
54
243
46
1,143
210,697
Neil G. Barry IV retweeted
First in the Human VECTOR PROCEDURE by Dr. Christopher Bruce during #SACIS2026 – at Riyadh, Kingdom of Saudi Arabia
2
16
82
10,657
Neil G. Barry IV retweeted
Transeptal puncture EchoNavigator guided and electrical knife assisted.
2
14
50
2,571
A fractured thrombectomy catheter embedded in a thrombosed femoral vein was successfully retrieved endovascularly while simultaneously removing the acute DVT and restoring venous flow. jvscit.org/article/S2468-428… @KECKSchool_USC @UWRadiology @JVascSurgCIT @cvirendo @_backtable
3
15
1,855
Neil G. Barry IV retweeted
Replying to @drjohnm
@drjohnm @jl35wilsonMD @HeartOTXHeartMD @djc795 @noahkaufmanmd How many cardiovascular clinics can schedule a treadmill ☢️ stress test, echocardiogram w Definity/GLS/3D, and a consult after testing on the same day for a patient w/ prior LAD stent (prob undersized 2.75mm), chest pain, and SOB? Some can. Most cannot. Patients appreciate it. #Efficiency
4
2
1
15
3,529
Neil G. Barry IV retweeted
Dyson’s new CameraJet toothbrush is a true feat of engineering, using AI to brush and floss simultaneously. Its intraoral camera spots gaps between teeth to fire a precision jet of mouthwash into these gaps. Developed over 6 years of research and trained using >470,000 dental images, the trained algorithm receives images from a 100,000 pixel, 1mm macro intraoral camera and is designed to identify, track and predict interdental gaps. During use, it analyses 28 frames/second and can trigger the fluid jet within 100 ms of detecting a gap. A stroboscopic light operates at 257Hz, deliberately out of phase with the rapidly moving brush head, to obtain interpretable images despite motion. Plaque mechanics also factored into the design. Dyson collaborated for 5 years with the University of Singapore’s Faculty of Dentistry to develop a lab model that mimicked dental plaque to permit repeated bench testing. Engineers used the model to optimise the geometry and fluid dynamics of the jet, leading to a conventional narrow/needle jet which punctures the model plaque, and a second broader conical jet to sweep plaque away over a larger area at lower pressure. The toothbrush of the future has well and truly arrived! 🙇🏻‍♂️🪥🦷
9
20
2
154
26,102
Neil G. Barry IV retweeted
Original Article: Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation (TAVI PCI trial) nej.md/3SlY3SF #ESCCongress | @escardio
1
25
5
74
41,993